ORYZON receives US patent allowance for vafidemstat BPD treatment

Go back to ORYZON receives US patent allowance for vafidemstat BPD treatment
ORION MARINE GROUP, Inc. (NYSE: ORN) Delayed: 9.15 +0.37 (4.21%)
Previous Close $8.78    52 Week High $9.48 
Open $8.93    52 Week Low $3.25 
Day High $9.30    P/E N/A 
Day Low $8.91    EPS $-0.01 
Volume 945,931